- CMS to require hospitals to report critical COVID-19 data on bed capacity, PPE and cases (fiercehealthcare.com)
The Trump administration is now going to require all hospitals to submit daily critical information on COVID-19, including bed capacity and the availability of essential supplies...The Centers for Medicare & Medicare Services released an emergency regulation...calling for the mandatory reporting. The agency also posted new requirements for lab reporting and revised a policy for physician and pharmacist orders for COVID-19 tests...“While many hospitals are voluntarily reporting this information now, not all are,” CMS said in a release. “The new rules make reporting a requirement of participation in the Medicare & Medicaid programs.”...READ MORE
- Sutter Health posts $857M loss in first half of 2020 due to COVID-19 (fiercehealthcare.com)
California-based Sutter Health suffered an $857 million loss in the first half of the year thanks to major declines in revenue due to the COVID-19 pandemic...“The need for Sutter to adjust its entire integrated network to respond to COVID-19 has been, and continues to be, a costly and difficult endeavor,”...Sutter experienced rapid declines in patient revenue in the first half of the year as states required the cancellation of elective procedures and patients were hesitant to come back to the hospital...Patient revenue from commercial plans suffered the most, generating $2.7 billion in revenue, a $543 million drop compared with the first half of 2019...Medicare revenue also declined by $179 million in the first half...Like other health systems, Sutter Health got $400 million from a $175 billion provider relief fund passed by Congress as part of the CARES Act...The system also got $1 billion from the Medicare Advance and Accelerated Payment program, which gave out advance Medicare payments to hospitals...Facilities have to start repaying the loans as soon as this month...READ MORE
- EPA approves a virus-killing coating for American Airlines, studies use by schools (reuters.com)Dallas company touts its spray-on coating as a COVID-19 killer for surfaces (dallasnews.com)
The U.S. Environmental Protection Agency said...it has granted emergency approval for American Airlines to use a disinfectant against the coronavirus on certain surfaces that lasts for up to seven days, and is studying whether it could be effective in places like schools...EPA Administrator Andrew Wheeler said at a news briefing that SurfaceWise2, made by Allied BioScience Inc, is the first long-lasting product approved by the agency to help fight the spread of the novel coronavirus...American Airlines will begin spraying its airplane cabins with the disinfectant in its home base of Texas after the state filed the request for emergency approval. The carrier hopes to eventually use it across its entire fleet, including its American Eagle regional partners...READ MORE
- PNG demands China explain COVID-19 vaccine trial on miners (apnews.com)
Papua New Guinea blocked the arrival of a flight carrying workers from China after a Chinese mine operator said its employees were given a coronavirus vaccine in a possible unauthorized trial…The Pacific nation’s pandemic response controller, David Manning, banned COVID-19 vaccine trials after Ramu NiCo Management Ltd. said it vaccinated Chinese employees… Manning said he ordered a flight carrying 180 Chinese workers turned back…as a precaution. He said he acted “in the best interests of our people” because of “possible risks or threat that it might cause.”… Manning said the National Department of Health had not approved any trials. He said any vaccines required approval by the World Health Organization and had to undergo “vigorous vaccine trials, protocols and procedures.”…READ MORE
- What is Gilead’s role in the war on Hydroxychloroquine? (americanthinker.com)
Is Gilead, the maker of Remdesivir, waging war on HCQ (hydroxychloroquine)? Attacks on the drug have been continuous ever since Dr. Didier Raoult used this quinine derivative to save the lives of COVID-19 patients last March. The first attempt to discredit HCQ was a hastily compiled Veterans Administration hospital system study last April. Notably, one of the study’s authors had in the past received numerous grants from Gilead...After deep flaws in the VA study were exposed, Surgisphere came to the rescue in May with a “15,000 patient” megastudy allegedly compiled from hospitals all over the world. This strategy succeeded: Following its publication in the Lancet and the NEJM, all outpatient use of HCQ was severely restricted...When the Surgisphere scam was exposed, both articles were quietly retracted and the editor-in-chief of the Lancet tried to wash his hands of this embarrassing incident by denouncing Surgisphere’s “monumental fraud.”...READ MORE
- Florida hospitals lost nearly $4B through end of June due to COVID-19: industry report (fiercehealthcare.com)
The COVID-19 pandemic cost Florida’s hospitals an estimated $3.8 billion in financial losses through the end of June, a new report from the Florida Hospital Association found...The report...also accounted for federal relief funds that were intended to help providers weather the financial crisis caused by COVID-19. The association said more funding is needed to help ensure the state’s hospitals are ready for a second surge of COVID-19.,,She said hospitals have faced increased staffing costs, lost revenue from delayed elective procedures and higher costs for personal protective equipment (PPE), testing supplies and vital drugs such as remdesivir...READ MORE
- FDA Authorizes Use of Blood Plasma to Treat Coronavirus (newsmax.com)UN cautions that virus plasma treatment still experimental (apnews.com)FDA's emergency nod for convalescent plasma sparks questions of whether it's bowing to Trump (fiercepharma.com)
The U.S. Food & Drug Administration...said it authorized the use of blood plasma from patients who have recovered from COVID-19 as a treatment for the disease...The FDA...said early evidence suggests blood plasma can decrease mortality and improve the health of patients when administered in the first three days of their hospitalization..."It appeared that the product is safe and we're comfortable with that and we continue to see no concerning safety signals," said Peter Marks, director of the Food and Drug Administration's Center for Biologics Evaluation and Research...The agency also said it determined this was a safe approach in an analysis of 20,000 patients who received this treatment...Patients who benefited the most from this treatment are those under 80 years old and who were not on a respirator, the agency said. Such patients had a 35 percent better survival rate a month after receiving the treatment...READ MORE
- Humana files suit against telehealth company QuivvyTech over millions in alleged false claims (fiercehealthcare.com)
Humana has filed suit against Florida-based telehealth company QuivvyTech, saying it was defrauded out of millions of dollars...filed in Southern Florida district court, QuivvyTech telemarketers would cold-call Humana members and ask them questions about common ailments. They would then wire that information to physicians who were in the scheme to secure prescriptions for pricey, unneeded creams...The physicians would prescribe these creams without ever speaking to the patient directly, according to the lawsuit. The prescriptions would then be wired to pharmacies that were also active participants in the scheme to be dispensed to members...One doctor, for instance, submitted 1,600 claims through the scheme to which Humana paid out more than $1.1 million, the insurer alleges in the suit...A New York pharmacy submitted 2,100 claims for one type of cream, for which Humana paid more than $2.5 million, the insurer alleges...READ MORE
- Industry Voices—As COVID-19 flare-ups continue, healthcare organizations must double down on drug diversion (fiercehealthcare.com)THE CONSEQUENCES OF COVID-19 ON THE OVERDOSEEPIDEMIC: OVERDOSESAREINCREASING (files.constantcontact.com)
Yet, while we’re hyper-focused fighting COVID-19, our country’s opioid epidemic is growing worse...A report released...suggests that overdose deaths have increased due to COVID-19. The Washington Post reported that suspected overdoses jumped 18% in March, 29% in April and 42% in May. The figures are based on data from ambulance teams, hospitals and police...What’s not being reported is the potential threat of drug diversion within healthcare settings, which is often undetected and underreported...Given the social, economic and healthcare implications of COVID-19, it’s not hard to see how drug diversion might escalate...data suggest a rise in depression and mental health disorders with the coronavirus stemming from isolation, "shelter at home" guidelines and the economic fallout of the pandemic. Healthcare providers, who are more likely to treat patients with COVID-19, may be more susceptible to mental health issues such as depression and burnout...READ MORE
- HHS allocates $1.4B to children’s hospitals affected by COVID-19 (fiercehealthcare.com)
The Trump administration released $1.4 billion to almost 80 children’s hospitals that have been impacted by the COVID-19 pandemic...The money comes out of a $175 billion fund Congress passed a few months ago to help providers that have been slammed by a financial crisis caused by the COVID-19 pandemic...“Children’s hospitals have seen decreasing patient visits and increased costs,” the Department of Health and Human Services said...“This distribution will help to ensure children’s hospitals receive relief funding proportional to other hospitals across the nation and providers caring for children are able to continue operating safely in some of our most vulnerable communities.”...HHS already gave out nearly $15 billion to safety hospitals and $11 billion to rural healthcare providers. The agency is also allocating funding to hospitals that have seen a high number of COVID-19 cases...READ MORE